Reckitt Benckiser Posts Strong Results on Emerging Market Performance

British consumer goods group Reckitt Benckiser said it expected to post annual revenue growth at the top end of forecasts after a strong emerging markets performance and demand for its brands such as Dettol and Strepsils helped it to post first half sales up 6 percent.

To boost growth Reckitt is putting greater focus on its fastest growing health and hygiene brands like Dettol, Strepsils and Durex, and is moving quicker into the key emerging markets of Brazil, Russia, India and China.

The maker of Nurofen painkillers and Cillit Bang cleaners also on Monday said it remained bullish on demand for its heroin addiction drug Suboxone, despite competition from cheaper versions in tablet form.

First half sales rose 6 percent on a constant exchange rate to 5 billion pounds ($7.69 billion).

Read more